GlassScriptPhysician profile
Amanda A Falco
NPI 1497201313
$1,982.11
in general payments reported to CMS, 2019-2025
31 companies · $528 in 2025
The $528 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $463 · 2022: $400 · 2023: $337 · 2024: $254 · 2025: $528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $351.27 | 2023-2025 | Eligard |
| Janssen Biotech, INC. | $300.26 | 2021-2025 | Erleada |
| Astellas Pharma US INC | $248.46 | 2021-2024 | Myrbetriq, Xtandi |
| Urovant Sciences INC | $120.30 | 2021-2022 | |
| Abbvie INC. | $101.91 | 2022-2024 | |
| Amgen INC. | $91.38 | 2021-2023 | Xgeva |
| Sumitomo Pharma America, INC. | $81.08 | 2024-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $74.12 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $69.47 | 2021-2025 | |
| Boston Scientific Corporation | $61.84 | 2021-2023 | Spaceoar Vue System - 10ml |
| Myovant Sciences INC. | $46.79 | 2022 | |
| Merck Sharp & Dohme LLC | $46.58 | 2021-2023 | Keytruda, Lynparza |
| Immunitybio, INC. | $45.27 | 2025 | |
| Civco Medical Instruments | $41.59 | 2023-2025 | |
| Verity Pharmaceuticals INC. | $30.01 | 2024-2025 | Trelstar |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $26.87 | 2021 | |
| Accord Healthcare, INC. | $19.09 | 2024 | |
| Inspire Medical Systems, INC. | $19.00 | 2025 | Inspire |
| Endo USA, INC. | $18.92 | 2025 | Xiaflex, Aveed |
| Teleflex LLC | $17.88 | 2021 | |
| Sunovion Pharmaceuticals INC. | $17.84 | 2021 | |
| Antares Pharma, INC. | $17.82 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $17.49 | 2021 | |
| Procept Biorobotics Corporation | $16.03 | 2023 | Aquabeam Robotic System |
| Endo Pharmaceuticals INC. | $15.48 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.45 | 2024 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $14.78 | 2023 | |
| Bioprotect Medical, INC. | $14.35 | 2024 | Bioprotect Balloon Implant System |
| Mission Pharmacal Company | $14.21 | 2021 | |
| Abc Home Medical Supply, INC. | $14.00 | 2025 | |
| Photocure INC | $12.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Falco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.